Evidence map›Paper›PMID 42178910›Full record

ReviewChemMedChem2026

Potential of Covalent Organic Framework in Pharmacy and Biomedicine: Influence of Structure on Properties and Applications.

Julia Kolodziejczyk, Marta E Plonska-Brzezinska

Abstract readReview
In one paragraph

Review in ChemMedChem, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Julia KolodziejczykDepartment of Organic Chemistry, Faculty of Medicine with the Division of Dentistry and Division of Medical Education in English, Medical University of Bialystok, Bialystok, Poland.
Marta E Plonska-BrzezinskaDepartment of Organic Chemistry, Faculty of Medicine with the Division of Dentistry and Division of Medical Education in English, Medical University of Bialystok, Bialystok, Poland.ORCID https://orcid.org/0000-0002-0538-6059

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Covalent organic frameworks (COFs) are a versatile class of crystalline porous materials with growing potential in pharmaceutical and biomedical applications due to their structural precision, modular chemistry, tunable porosity, and emerging biocompatibility. Unlike prior reviews centered mainly on individual applications, this review adopts a structure-property-bioperformance-translation framework to clarify how COF design governs biological function and clinical promise. We analyze how linkage chemistry, topology, pore environment, surface properties, and particle engineering influence protein corona formation, biodistribution, degradation, therapeutic efficacy, and safety. Particular attention is given to translational challenges still under-represented in the literature, including synthesis under biomedical constraints, scalability, reproducibility, residual solvent and impurity control, sterilization, green chemistry, and regulatory compatibility. We further discuss the expanding roles of COFs in drug and biomacromolecule delivery, photodynamic, photothermal, and chemodynamic therapy, as well as in emerging immunotherapeutic and combination treatment platforms. Antimicrobial, wound-healing, diagnostic, and imaging applications are also considered, with emphasis on the relationship between framework design and functional performance. Disease-oriented case studies supported by in vivo evidence highlight both opportunities and current limitations across cancer, infectious, and cardiovascular models. This review outlines key principles for translating COFs into clinically relevant therapeutics and diagnostics.

Indexed as

Metal-Organic FrameworksAnimalsBiocompatible MaterialsHumansMolecular StructurePorosityBiocompatible MaterialsMetal-Organic Frameworksbiomaterialsbiomedical applicationscovalent organic frameworkspharmaceutical potentialporous materials

Identifiers

PMID42178910
PMCPMC13206568

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.